Citation 141841

ATOPKINA,LN: MALINOVSKAVA,GV: ELYAKOV,GB: UVAROVA,NI: WOERDENBAG,HJ: KOULMAN,A: PRAS,N: POTIER,P:. (1999). CYTOTOXICITY OF NATURAL GINSENG GLYCOSIDES AND SEMISYNTHETIC ANALOGUES.. 65(1)

Citation Details

Title	CYTOTOXICITY OF NATURAL GINSENG GLYCOSIDES AND SEMISYNTHETIC ANALOGUES.
Authors	ATOPKINA,LN: MALINOVSKAVA,GV: ELYAKOV,GB: UVAROVA,NI: WOERDENBAG,HJ: KOULMAN,A: PRAS,N: POTIER,P:
Year	1999
Volume	65
Issue	1

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RG-1	WEAK ACTIVITY
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RG-1	WEAK ACTIVITY
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RE	WEAK ACTIVITY
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RE	WEAK ACTIVITY
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RF	WEAK ACTIVITY
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RF	WEAK ACTIVITY
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE F-1	WEAK ACTIVITY
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE F-1	WEAK ACTIVITY
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RD	WEAK ACTIVITY
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RD	WEAK ACTIVITY
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RB-1	WEAK ACTIVITY
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RB-1	WEAK ACTIVITY
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RB-2	WEAK ACTIVITY
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RB-2	WEAK ACTIVITY
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RC	WEAK ACTIVITY
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RC	WEAK ACTIVITY
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RO	WEAK ACTIVITY
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RO	WEAK ACTIVITY
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PANAXADIOL,PROTO: 20(S):	ACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PANAXADIOL,PROTO: 20(S):	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-BETA-20(S) DIOL-12-ONE	ACTIVE
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-BETA-20(S) DIOL-12-ONE	ACTIVE
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RH-2	ACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE RH-2	ACTIVE
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-BETA-12-BETA-20(S)-TRIOL,3-O-BETA-D-GLUCOPYRANOSYL:	WEAK ACTIVITY
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-BETA-12-BETA-20(S)-TRIOL,3-O-BETA-D-GLUCOPYRANOSYL:	WEAK ACTIVITY
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE F-2	WEAK ACTIVITY
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GINSENOSIDE F-2	WEAK ACTIVITY
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHIKUSETSUSAPONIN LT-8	ACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHIKUSETSUSAPONIN LT-8	ACTIVE
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BETULAFOLIENETRIOL	ACTIVE
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BETULAFOLIENETRIOL	ACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-ALPHA-12-BETA-20(S)-TRIOL,3-O-BETA-GLUCOPYRANOSYL:	ACTIVE
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-ALPHA-12-BETA-20(S)-TRIOL,3-O-BETA-GLUCOPYRANOSYL:	ACTIVE
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-ALPHA-12-BETA-20(S)-TRIOL,12-O-BETA-D-GLUCOPYRANOSYL:	ACTIVE
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-ALPHA-12-BETA-20(S)-TRIOL,12-O-BETA-D-GLUCOPYRANOSYL:	ACTIVE
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-ALPHA-12-BETA-20(S)-TRIOL,20-O-BETA-D-GLUCOPYRANOSYL:	ACTIVE
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-ALPHA-12-BETA-20(S)-TRIOL,20-O-BETA-D-GLUCOPYRANOSYL:	ACTIVE
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-ALPHA-12-BETA-20(S)-TRIOL,3-12-DI-O-BETA-D-GLUCOPYRANOSYL:	WEAK ACTIVITY
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-ALPHA-12-BETA-20(S)-TRIOL,3-12-DI-O-BETA-D-GLUCOPYRANOSYL:	WEAK ACTIVITY
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-ALPHA-12-BETA-20(S)-TRIOL,3-20-DI-O-BETA-D-GLUCOPYRANOSYL:	WEAK ACTIVITY
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-ALPHA-12-BETA-20(S)-TRIOL,3-20-DI-O-BETA-D-GLUCOPYRANOSYL:	WEAK ACTIVITY
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-BETA-12-BETA-20(S)-TRIOL,12-O-BETA-D-GLUCOPYRANOSYL:	ACTIVE
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-BETA-12-BETA-20(S)-TRIOL,12-O-BETA-D-GLUCOPYRANOSYL:	ACTIVE
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-BETA-12-BETA-20(S)-TRIOL,3-12-DI-O-BETA-D-GLUCOPYRANOSYL:	EQUIVOCAL
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMAR-24-ENE-3-BETA-12-BETA-20(S)-TRIOL,3-12-DI-O-BETA-D-GLUCOPYRANOSYL:	EQUIVOCAL
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BETULAFOLIENETRIOL OXIDE	ACTIVE
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BETULAFOLIENETRIOL OXIDE	ACTIVE
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,3-O-BETA-D-GLUCOPYRANOSYL 20(S)-24(R)-EPOXY:	ACTIVE
50	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,3-O-BETA-D-GLUCOPYRANOSYL 20(S)-24(R)-EPOXY:	WEAK ACTIVITY
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,12-O-BETA-D-GLUCOPYRANOSYL 20(S)-24(R)-EPOXY:	WEAK ACTIVITY
52	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,12-O-BETA-D-GLUCOPYRANOSYL 20(S)-24(R)-EPOXY:	WEAK ACTIVITY
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,25-O-BETA-D-GLUCOPYRANOSYL 20(S)-24(R)-EPOXY:	WEAK ACTIVITY
54	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,25-O-BETA-D-GLUCOPYRANOSYL 20(S)-24(R)-EPOXY:	WEAK ACTIVITY
55	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,12-25-DI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	EQUIVOCAL
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,12-25-DI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	EQUIVOCAL
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,3-12-DI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	EQUIVOCAL
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,3-12-DI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	EQUIVOCAL
59	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,3-12-25-TRI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	EQUIVOCAL
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-25-TRIOL,3-12-25-TRI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	EQUIVOCAL
61	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-BETA-12-BETA-25-TRIOL,20(S)-24(R)-EPOXY:	WEAK ACTIVITY
62	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-BETA-12-BETA-25-TRIOL,20(S)-24(R)-EPOXY:	ACTIVE
63	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-BETA-12-BETA-25-TRIOL,3-O-BETA-D-GLUCOPYRANOSYL 20(S)-24(R)-EPOXY:	WEAK ACTIVITY
64	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-BETA-12-BETA-25-TRIOL,3-O-BETA-D-GLUCOPYRANOSYL 20(S)-24(R)-EPOXY:	WEAK ACTIVITY
65	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-BETA-12-BETA-25-TRIOL,12-O-BETA-D-GLUCOPYRANOSYL-20*S)-24(R)-EPOXY:	WEAK ACTIVITY
66	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-BETA-12-BETA-25-TRIOL,12-O-BETA-D-GLUCOPYRANOSYL-20*S)-24(R)-EPOXY:	EQUIVOCAL
67	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-BETA-12-BETA-25-TRIOL,3-12-DI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	EQUIVOCAL
68	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-BETA-12-BETA-25-TRIOL,3-12-DI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	EQUIVOCAL
69	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-BETA-12-BETA-25-TRIOL,3-12-25-TRI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	EQUIVOCAL
70	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-BETA-12-BETA-25-TRIOL,3-12-25-TRI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	INACTIVE
71	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-17-ALPHA-25-TETRAOL,20(S)-24(R)-EPOXY:	WEAK ACTIVITY
72	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-17-ALPHA-25-TETRAOL,20(S)-24(R)-EPOXY:	ACTIVE
73	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-17-ALPHA-25-TETRAOL,3-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	WEAK ACTIVITY
74	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-17-ALPHA-25-TETRAOL,3-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	INACTIVE
75	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-17-ALPHA-25-TETRAOL,12-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	WEAK ACTIVITY
76	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-17-ALPHA-25-TETRAOL,12-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	WEAK ACTIVITY
77	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-17-ALPHA-25-TETRAOL,3-12-DI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	EQUIVOCAL
78	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-17-ALPHA-25-TETRAOL,3-12-DI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	INACTIVE
79	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-17-ALPHA-25-TETRAOL,3-12-25-TRI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	EQUIVOCAL
80	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-12-BETA-17-ALPHA-25-TETRAOL,3-12-25-TRI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	INACTIVE
81	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-25-DIOL,3-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	WEAK ACTIVITY
82	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-25-DIOL,3-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	WEAK ACTIVITY
83	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-25-DIOL,3-25-DI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	WEAK ACTIVITY
84	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-3-ALPHA-25-DIOL,3-25-DI-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	INACTIVE
85	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-12-BETA-25-DIOL-3-ONE,20(S)-24(R)-EPOXY:	WEAK ACTIVITY
86	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-12-BETA-25-DIOL-3-ONE,20(S)-24(R)-EPOXY:	ACTIVE
87	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-12-BETA-25-DIOL-3-ONE,12-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	WEAK ACTIVITY
88	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE-12-BETA-25-DIOL-3-ONE,12-O-BETA-D-GLUCOPYRANOSYL-20(S)-24(R)-EPOXY:	WEAK ACTIVITY

Citation 141841

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1